Blenrep

belantamab mafodotin · GSK

Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for Blenrep, covering 2023-09-15 to 2026-08-26. Get the full timeline:

Most recent: EMA Authorised: Blenrep (belantamab mafodotin) — GlaxoSmithKline Trading Services Limited